Exploring the Effects of Oncolytic Viruses on the NK Cell Killing of Solid Tumors

https://openworks.mdanderson.org/sumexp22/1074/thumbnail.jp

Understanding Virally Induced NK Cell Memory: HLAs as a Potential Mechanism

https://openworks.mdanderson.org/sumexp23/1010/thumbnail.jp

Effect of Expansion and Tumor Challenge on Chemokine Receptor Expression in Cord Blood-Derived CAR-NK Cells

https://openworks.mdanderson.org/sumexp23/1055/thumbnail.jp

Multimodal Analysis of the Interaction Between CD70-Directed Chimeric Antigen Receptor Natural Killer Cells and Target Tumors

https://openworks.mdanderson.org/sumexp22/1062/thumbnail.jp

Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes

Immune suppression after oncologic surgery is a common phenomenon. Several studies have demonstrated that it is associated with poor survival owing to cancer progression. Immunotherapy, especially NK cell transfer therapy, is an attractive alternative because current methodologies to isolate, generate, and expand NK cells have shown good safety profiles in current active investigations. We believe that the use of NK cell transfer therapy in the context of postoperative minimal residual disease deserves significant investigation

Combination therapy of oncolytic adenovirus with NK cells for the treatment of aggressive solid tumors

https://openworks.mdanderson.org/sumexp21/1021/thumbnail.jp